Press Contact
Ellen Mullally
Phone: 410-992-3124
Email: emullally@paltmed.org
JAMDA
October 14, 2019
Showing 4811 - 4820 of 8410 results
JAMDA
October 14, 2019
Motoric Cognitive Risk Syndrome in a Chinese Older Adult Population: Prevalence and Associated Factors
Podcast
October 14, 2019
JAMDA On-The-Go | October 2019
JAMDA
October 11, 2019
A Randomized Trial of Alerting to Hypocholesterolemia Results of the Low Indexes of Metabolism Intervention Trial-C (LIMIT-C)
The benefit of alerting clinical staff to drug-induced hypocholesterolemia in patients aged 75 years and older remains uncertain.
JAMDA
October 11, 2019
Predictors of Incident Fear of Falling in Community-Dwelling Older Adults
Fear of falling (FoF) is common in older people and may lead to physical decline, disability, poor quality of life, and falls. Several risk factors for FoF have been identified in cross-sectional studies, but evidence on predictors of its incidence is scarce. We investigated the latter in community-dwellin...
JAMDA
October 10, 2019
Safety of Subcutaneous Piperacillin/Tazobactam Administration Compared to Intravenous Administration: Propensity Score–Matched Cohort Study
JAMDA
October 10, 2019
Lessons Learned From Implementation of the Indiana SMART Campaign to Reduce Nursing Home Polypharmacy
JAMDA
October 8, 2019
Sleep Duration and the Risk of Dementia: A Systematic Review and Meta-analysis of Prospective Cohort Studies
Epidemiologic studies have reported inconsistent findings about the association between sleep duration and the risk of dementia. We aimed to clarify this association by method of meta-analysis.
JAMDA
October 8, 2019
Cognitive Outcomes of Long-term Benzodiazepine and Related Drug (BDZR) Use in People Living With Mild to Moderate Alzheimer's Disease: Results From NILVAD
Benzodiazepines and related drugs (BDZRs) have been associated with an increased risk of Alzheimer's disease (AD) in later life. Despite this, it remains unclear whether ongoing BDZR use may further accelerate cognitive decline in those diagnosed with mild to moderate AD.
Podcast
October 7, 2019